Poly Medicure Valuation Multiples

Poly Medicure Overview

About Poly Medicure

Poly Medicure Ltd engages in the manufacturing and sale of medical devices. It offers disposable medical devices for infusion therapy, blood management, gastroenterology, vascular access, surgery and wound drainage, anesthesia, and urology. Some of its products include Ventilator Circuit Combo Kits, Bain Circuits, Safety Introducer Needles, High-Pressure Vaccum Bottle-Triplet, Catheters, and others. Geographically, it derives a majority of its revenue from exports. The company operates under one segment namely Medical Devices.

Founded

1995

HQ

Employees

3.1K

Website

polymedicure.com

Sectors

Medical DevicesBioTech

Financials (LTM)

Revenue: $205M

EBITDA: $49M

EV

$1B

Valuation Multiples

Multiples.vc

Start free trial

Poly Medicure Financials

Poly Medicure reported last 12-month revenue of $205M and EBITDA of $49M.

In the same LTM period, Poly Medicure generated $141M in gross profit, $49M in EBITDA, and $38M in net income.

Poly Medicure P&L

In the most recent fiscal year, Poly Medicure reported revenue of $197M and EBITDA of $59M.

Poly Medicure expects next 12-month revenue of XXX and NTM EBITDA of XXX

Poly Medicure Stock Performance

Poly Medicure has current market cap of $2B, and enterprise value of $1B.

Poly Medicure's stock price is $15.72.

Poly Medicure Valuation Multiples

Poly Medicure trades at 7.3x EV/Revenue multiple, and 30.5x EV/EBITDA.

Poly Medicure Financial Valuation Multiples

As of April 22, 2026, Poly Medicure has market cap of $2B and EV of $1B.

Equity research analysts estimate Poly Medicure's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Poly Medicure has a P/E ratio of 41.4x.

Poly Medicure Margins & Growth Rates

Poly Medicure's revenue in the last 12 month grew by 20%.

Poly Medicure's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.

Poly Medicure's rule of 40 is 43% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Poly Medicure's rule of X is 71% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Poly Medicure Public Comps

See public comps and valuation multiples for other Medical Devices comps.

Poly Medicure M&A Activity

Poly Medicure acquired XXX companies to date.

Last acquisition by Poly Medicure was on XXXXXXXX, XXXXX. Poly Medicure acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Poly Medicure Investment Activity

Poly Medicure invested in XXX companies to date.

Poly Medicure made its latest investment on XXXXXXXX, XXXXX. Poly Medicure invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).